Massachusetts Bill to Prevent Pre-Employment Marijuana Testing Advances in Legislature

Legislation preventing employers from testing potential employees for marijuana until after they’ve been offered conditional employment, while offering extra employee protections for medical marijuana patients, is advancing in the Massachusetts Legislature.

House Bill 1955, filed last year by State Representatives Chynah Tyler and David LeBoeuf, received approval recently through the Joint Committee on Labor and Workforce Development. Currently in the House Steering, Policy and Scheduling, the measure has been scheduled for a second reading later today.

“An employer may only test a prospective employee for marijuana use after a conditional offer of employment has been extended, unless otherwise required by law”, states the bill. “Further, no employer or agent of an employer may directly or indirectly solicit or require an employee or prospective employee to submit to testing for the presence of marijuana in his or her system as a condition of employment”.

In addition, House Bill 1955 offers additional protections to patients, stating that “an employer may not refuse to hire, terminate from employment, penalize, fail to promote, or otherwise take adverse employment action against an individual based upon the individual’s status as a qualifying patient unless the individual used, possessed, or was impaired by marijuana at the individual’s place of employment or during the hours of employment.”

Furthermore, the measure states that “A qualifying patient’s failure to pass an employer-administered drug test for marijuana components or metabolites may not be used as a basis for employment-related decisions unless reasonable suspicion exists that the qualified patient was impaired by marijuana at the qualifying patient’s place of employment or during the hours of employment”.

In Massachusetts, medical marijuana was legalized in 2012, with recreational marijuana legalized for those 21 and older in 2016. According to data compiled and released by the Massachusetts Cannabis Control Commission (CCC), there was $143.2 million worth of marijuana and marijuana products sold in February, roughly $10 million more than the total for February, 2023. All-time legal marijuana sales for the state now stands at $7.05 billion.

Last month Governor Maura T. Healey announced that she is taking executive action to pardon misdemeanor marijuana possession convictions in Massachusetts, calling it “the most comprehensive action by a governor since President Joe Biden pardoned federal marijuana possession convictions and called on governors to take similar actions in their states”.

Thank you for reading The Marijuana Herald! You can find more news stories by clicking here, and you can sign up for daily news updates by clicking here

 

 

 

More articles from The Marijuana Herald can be found below.

Kentucky Lawmakers File Bill to Expand List of Medical Cannabis Conditions, Allow Home Grow

Kentucky Lawmakers File Bill to Expand List of Medical Cannabis Conditions, Allow Home Grow

The Top-Selling Cannabis Strains in Every Recreational State (January 2026)

The Top-Selling Cannabis Strains in Every Recreational State (January 2026)

Kentucky Opens Second Medical Marijuana Dispensary and First Processing Facility

Kentucky Opens Second Medical Marijuana Dispensary and First Processing Facility

Washington Bill Would Set Framework for Interstate Marijuana Commerce

Washington Bill Would Set Framework for Interstate Marijuana Commerce

Michigan Cannabis Sales Top $3.2 Billion in 2025 as Price Drops to All-Time Low of $58 Per Ounce

Michigan Cannabis Sales Top $3.2 Billion in 2025 as Price Drops to All-Time Low of $58 Per Ounce

Utah Bill Would Remove Criminal Penalties for First-Time Marijuana Possession of Up to 14 Grams, Reduce Penalties for Subsequent Offenses

Utah Bill Would Remove Criminal Penalties for First-Time Marijuana Possession of Up to 14 Grams, Reduce Penalties for Subsequent Offenses

Curaleaf Opens 160th U.S. Retail Location With New Medical Marijuana Dispensary in Florida

Curaleaf Opens 160th U.S. Retail Location With New Medical Marijuana Dispensary in Florida

Study: Cannabis-Infused Beverages Linked to Reduced Alcohol Use and Fewer Binge Drinking Episodes

Study: Cannabis-Infused Beverages Linked to Reduced Alcohol Use and Fewer Binge Drinking Episodes

West Virginia Lawmakers Propose Putting Marijuana Legalization Constitutional Amendment on 2026 Ballot

West Virginia Lawmakers Propose Putting Marijuana Legalization Constitutional Amendment on 2026 Ballot

Colorado Senate Bill Would Require Health Facilities to Allow Medical Marijuana Use by Terminally Ill Patients

Colorado Senate Bill Would Require Health Facilities to Allow Medical Marijuana Use by Terminally Ill Patients

West Virginia Bills Filed to Decriminalize Cannabis Possession, Protect Gun Rights for Medical Cannabis Patients

West Virginia Bills Filed to Decriminalize Cannabis Possession, Protect Gun Rights for Medical Cannabis Patients

Maryland Bill Would Direct Cannabis Tax Revenue to Veterans Trust Fund

Maryland Bill Would Direct Cannabis Tax Revenue to Veterans Trust Fund

Mississippi Senator Files Companion Bill to Decriminalize First-Time Marijuana Possession

Mississippi Senator Files Companion Bill to Decriminalize First-Time Marijuana Possession

Oklahoma Medical Marijuana Program Reports 319,965 Active Patients and 4,500 Licensed Businesses

Oklahoma Medical Marijuana Program Reports 319,965 Active Patients and 4,500 Licensed Businesses

Florida Medical Marijuana Program Reaches 740 Dispensaries

Florida Medical Marijuana Program Reaches 740 Dispensaries

Safe Harbor Expands Into Cannabis Insurance Through New Industry Partnerships

Safe Harbor Expands Into Cannabis Insurance Through New Industry Partnerships

Study: Psilocybin Treatment May Benefit Those With PTSD

Study: Psilocybin Treatment May Benefit Those With PTSD

Psilocybin Found to Significantly Reduce Depression in Cancer Patients, Meta-Analysis Shows

Psilocybin Found to Significantly Reduce Depression in Cancer Patients, Meta-Analysis Shows